Intermediate phosphorylation reactions in the mechanism of ATP utilization by the copper ATPase (CopA) of Thermotoga maritima

被引:29
作者
Hatori, Yuta [1 ]
Hirata, Ayami [1 ]
Toyoshima, Chikashi [1 ]
Lewis, David [2 ]
Pilankatta, Rajendra [2 ]
Inesi, Giuseppe [2 ]
机构
[1] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan
[2] Calif Pacific Med Ctr, Res Inst, San Francisco, CA 94107 USA
关键词
D O I
10.1074/jbc.M802735200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recombinant and purified Thermotoga maritima CopA sustains ATPase velocity of 1.78-2.73 mu mol/mg/min in the presence of Cu+ (pH 6, 60 degrees C) and 0.03-0.08 mu mol/mg/min in the absence of Cu+. High levels of enzyme phosphorylation are obtained by utilization of [gamma-P-32]ATP in the absence of Cu+. This phosphoenzyme decays at a much slower rate than observed with Cu.E1 similar to P. In fact, the phosphoenzyme is reduced to much lower steady state levels upon addition of Cu+, due to rapid hydrolytic cleavage. Negligible ATPase turnover is sustained by CopA following deletion of its N-metal binding domain (Delta NMBD) or mutation of NMBD cysteines (CXXC). Nevertheless, high levels of phosphoenzyme are obtained by utilization of [gamma-P-32]ATP by the Delta NMBD and CXXC mutants, with no effect of Cu+ either on its formation or hydrolytic cleavage. Phosphoenzyme formation (E2P) can also be obtained by utilization of Pi, and this reaction is inhibited by Cu+ (E2 to E1 transition) even in the Delta NMBD mutant, evidently due to Cu+ binding at a (transport) site other than the NMBD. E2P undergoes hydrolytic cleavage faster in Delta NMBD and slower in CXXC mutant. We propose that Cu+ binding to the NMBD is required to produce an "active" conformation of CopA, whereby additional Cu+ bound to an alternate (transmembrane transport) site initiates faster cycles including formation of Cu.E1 similar to P, followed by the E1 similar to P to E2-P conformational transition and hydrolytic cleavage of phosphate. An H479Q mutation (analogous to one found in Wilson disease) renders CopA unable to utilize ATP, whereas phosphorylation by P-i is retained.
引用
收藏
页码:22541 / 22549
页数:9
相关论文
共 49 条
[1]   Identification of ion-selectivity determinants in heavy-metal transport P1B-type ATPases [J].
Argüello, JM .
JOURNAL OF MEMBRANE BIOLOGY, 2003, 195 (02) :93-108
[2]   Evolution of substrate specificities in the P-type ATPase superfamily [J].
Axelsen, KB ;
Palmgren, MG .
JOURNAL OF MOLECULAR EVOLUTION, 1998, 46 (01) :84-101
[3]   THE WILSON DISEASE GENE IS A PUTATIVE COPPER TRANSPORTING P-TYPE ATPASE SIMILAR TO THE MENKES GENE [J].
BULL, PC ;
THOMAS, GR ;
ROMMENS, JM ;
FORBES, JR ;
COX, DW .
NATURE GENETICS, 1993, 5 (04) :327-337
[4]   WILSON DISEASE AND MENKES DISEASE - NEW HANDLES ON HEAVY-METAL TRANSPORT [J].
BULL, PC ;
COX, DW .
TRENDS IN GENETICS, 1994, 10 (07) :246-252
[5]   Evolutionary genomics of the HAD superfamily: Understanding the structural adaptations and catalytic diversity in a superfamily of phosphoesterases and allied enzymes [J].
Burroughs, A. Maxwell ;
Allen, Karen N. ;
Dunaway-Mariano, Debra ;
Aravind, L. .
JOURNAL OF MOLECULAR BIOLOGY, 2006, 361 (05) :1003-1034
[6]   Membrane structure of CtrA3, a copper-transporting P-type-ATPase from Aquifex aeolicus [J].
Chintalapati, Sivaram ;
Al Kurdi, Rana ;
van Scheltinga, Anke C. Terwisscha ;
Kuehlbrandt, Werner .
JOURNAL OF MOLECULAR BIOLOGY, 2008, 378 (03) :581-595
[7]   BeF3- acts as a phosphate analog in proteins phosphorylated on aspartate:: Structure of a BeF3- complex with phosphoserine phosphatase [J].
Cho, H ;
Wang, WR ;
Kim, R ;
Yokota, H ;
Damo, S ;
Kim, SH ;
Wemmer, D ;
Kustu, S ;
Yan, DL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (15) :8525-8530
[8]   Copper transfer from the Cu(I) chaperone, CopZ, to the repressor, Zn(II)CopY: Metal coordination environments and protein interactions [J].
Cobine, PA ;
George, GN ;
Jones, CE ;
Wickramasinghe, WA ;
Solioz, M ;
Dameron, CT .
BIOCHEMISTRY, 2002, 41 (18) :5822-5829
[9]  
de Meis L, 1974, Biochemistry, V13, P5032, DOI 10.1021/bi00721a026
[10]   Solution structure of the N-domain of Wilson disease protein: Distinct nucleotide-binding environment and effects of disease mutations [J].
Dmitriev, O ;
Tsivkovskii, R ;
Abildgaard, F ;
Morgan, CT ;
Markley, JL ;
Lutsenko, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (14) :5302-5307